Robust SARS-CoV-2 antibody and T cell immunity following three COVID-19 vaccine doses in inflammatory bowel disease patients receiving anti-TNF or alternative treatments https://www.medrxiv.org/content/10.1101/2022.12.13.22283434
Robust SARS-CoV-2 antibody and T cell immunity following three COVID-19 vaccine doses in inflammatory bowel disease patients receiving anti-TNF or alternative treatments https://www.medrxiv.org/content/10.1101/2022.12.13.22283434